Related Experiment Video
Updated: Jul 20, 2026
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
Published on: February 2, 2013
A framework integrating multiscale in-silico modeling and experimental data predicts CD33CAR-NK cytotoxicity across
Saeed Ahmad1, Kun Xing2,3, Harshana Rajakaruna1
1Steve and Cindy Rasmussen Institute for Genomic Medicine, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH.
Abstract:
Uncovering mechanisms and predicting tumor cell responses to CAR-NK cytotoxicity is essential for improving therapeutic efficacy. Currently, the complexity of these effector-target interactions and the donor-to-donor variations in NK cell receptor (NKR) repertoire require functional assays to be performed experimentally for each manufactured CAR-NK cell product and target combination. Here, we developed a computational mechanistic multiscale model which considers heterogenous expression of CARs, NKRs, adhesion receptors and their cognate ligands, signal transduction, and NK cell-target cell population kinetics. The model trained with quantitative flow cytometry and in vitro cytotoxicity data accurately predicts the short- and long-term cytotoxicity of CD33CAR-NK cells against leukemia cell lines across multiple CAR designs. Furthermore, using Pareto optimization we explored the effect of CAR proportion and NK cell signaling on the differential cytotoxicity of CD33CAR-NK cells to cancer and healthy cells. This model can be extended to predict CAR-NK cytotoxicity across many antigens and tumor targets.
Insights
We developed a computational model to predict CAR-NK cell therapy efficacy. This tool accurately forecasts tumor cell killing, optimizing cancer treatments by understanding complex immune cell interactions.
Area of Science:
- Immunology
- Computational Biology
- Biotechnology
Background:
- Predicting CAR-NK cell efficacy is crucial for cancer immunotherapy.
- Current methods rely on experimental assays, which are time-consuming and don't account for donor variability.
Purpose of the Study:
- To develop a computational model for predicting CAR-NK cell cytotoxicity.
- To understand the mechanisms underlying CAR-NK cell effector-target interactions.
Main Methods:
- A multiscale computational model was developed, integrating CAR, NKR, and ligand expression, signal transduction, and cell kinetics.
- The model was trained using flow cytometry and in vitro cytotoxicity data.
- Pareto optimization was used to explore the impact of CAR expression and signaling on cytotoxicity.
Main Results:
- The model accurately predicted short- and long-term cytotoxicity of CD33CAR-NK cells against leukemia cell lines.
- It demonstrated the influence of CAR proportion and NK cell signaling on differential cytotoxicity against cancer versus healthy cells.
Conclusions:
- This computational model offers a powerful tool for predicting CAR-NK cell therapy outcomes.
- It can be extended to various antigens and tumor targets, advancing personalized cancer immunotherapy.
